GlobeNewswire Inc.··NaMolecular Partners to Showcase Experimental Cancer Therapy MP0712 at Major 2026 Conferences
Molecular Partners will present its DLL3-targeting Radio-DARPin candidate MP0712 at three major scientific conferences in May 2026, highlighting early clinical trial data.
MOLNclinical developmentsmall cell lung cancer